Because the SLC family transports a wide variety of substrates, including anticancer drugs, the mechanisms by which SLC proteins modulate MDR are mainly due to the decrease in drug uptake into tumor cells mediated by the low expression of certain SLCs.96, 97. The gene discussed is CCL21; the disease is neoplasm.